Endostatin gene variation and protein levels in breast cancer susceptibility and severity
<p>Abstract</p> <p>Background</p> <p>Endostatin is a potent endogenous anti-angiogenic agent which inhibits tumour growth. A non-synonymous coding polymorphism in the Endostatin gene is thought to affect Endostatin activity. We aimed to determine the role of this Endost...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-06-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/7/107 |
| _version_ | 1811260515973857280 |
|---|---|
| author | Cox Angela Globe Jenny Cross Simon S Balasubramanian Sabapathy P Brown Nicola J Reed Malcolm W |
| author_facet | Cox Angela Globe Jenny Cross Simon S Balasubramanian Sabapathy P Brown Nicola J Reed Malcolm W |
| author_sort | Cox Angela |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Endostatin is a potent endogenous anti-angiogenic agent which inhibits tumour growth. A non-synonymous coding polymorphism in the Endostatin gene is thought to affect Endostatin activity. We aimed to determine the role of this Endostatin polymorphism in breast cancer pathogenesis and any influence on serum Endostatin levels in healthy volunteers. Endostatin protein expression on a breast cancer micro array was also studied to determine any relationship to genotype and to breast cancer prognosis.</p> <p>Methods</p> <p>The 4349G > A (coding non-synonymous) polymorphism in exon 42 of the Endostatin gene was genotyped in approximately 846 breast cancer cases and 707 appropriate controls. In a separate healthy cohort of 57 individuals, in addition to genotyping, serum Endostatin levels were measured using enzyme linked immunosorbant assay (ELISA). A semi-quantitative assessment of Endostatin protein expression on immunostained tissue micro arrays (TMA) constructed from breast cancer samples of patients with genotype data was performed.</p> <p>Results</p> <p>The rare allele (A) was significantly associated with invasive breast cancers compared to non-invasive tumours (p = 0.03), but there was no association with tumour grade, nodal status, vascular invasion or overall survival. There was no association with breast cancer susceptibility. Serum Endostatin levels and Endostatin protein expression on the tissue micro array were not associated with genotype.</p> <p>Conclusion</p> <p>The Endostatin 4349A allele is associated with invasive breast cancer. The Endostatin 4349G > A polymorphism however does not appear to be associated with breast cancer susceptibility or severity in invasive disease. By studying circulating levels and tumour Endostatin protein expression, we have shown that any influence of this polymorphism is unlikely to be through an effect on the levels of protein produced.</p> |
| first_indexed | 2024-04-12T18:48:31Z |
| format | Article |
| id | doaj.art-d2d71bc195de4da0a69cb5cd5b2e3c11 |
| institution | Directory Open Access Journal |
| issn | 1471-2407 |
| language | English |
| last_indexed | 2024-04-12T18:48:31Z |
| publishDate | 2007-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj.art-d2d71bc195de4da0a69cb5cd5b2e3c112022-12-22T03:20:33ZengBMCBMC Cancer1471-24072007-06-017110710.1186/1471-2407-7-107Endostatin gene variation and protein levels in breast cancer susceptibility and severityCox AngelaGlobe JennyCross Simon SBalasubramanian Sabapathy PBrown Nicola JReed Malcolm W<p>Abstract</p> <p>Background</p> <p>Endostatin is a potent endogenous anti-angiogenic agent which inhibits tumour growth. A non-synonymous coding polymorphism in the Endostatin gene is thought to affect Endostatin activity. We aimed to determine the role of this Endostatin polymorphism in breast cancer pathogenesis and any influence on serum Endostatin levels in healthy volunteers. Endostatin protein expression on a breast cancer micro array was also studied to determine any relationship to genotype and to breast cancer prognosis.</p> <p>Methods</p> <p>The 4349G > A (coding non-synonymous) polymorphism in exon 42 of the Endostatin gene was genotyped in approximately 846 breast cancer cases and 707 appropriate controls. In a separate healthy cohort of 57 individuals, in addition to genotyping, serum Endostatin levels were measured using enzyme linked immunosorbant assay (ELISA). A semi-quantitative assessment of Endostatin protein expression on immunostained tissue micro arrays (TMA) constructed from breast cancer samples of patients with genotype data was performed.</p> <p>Results</p> <p>The rare allele (A) was significantly associated with invasive breast cancers compared to non-invasive tumours (p = 0.03), but there was no association with tumour grade, nodal status, vascular invasion or overall survival. There was no association with breast cancer susceptibility. Serum Endostatin levels and Endostatin protein expression on the tissue micro array were not associated with genotype.</p> <p>Conclusion</p> <p>The Endostatin 4349A allele is associated with invasive breast cancer. The Endostatin 4349G > A polymorphism however does not appear to be associated with breast cancer susceptibility or severity in invasive disease. By studying circulating levels and tumour Endostatin protein expression, we have shown that any influence of this polymorphism is unlikely to be through an effect on the levels of protein produced.</p>http://www.biomedcentral.com/1471-2407/7/107 |
| spellingShingle | Cox Angela Globe Jenny Cross Simon S Balasubramanian Sabapathy P Brown Nicola J Reed Malcolm W Endostatin gene variation and protein levels in breast cancer susceptibility and severity BMC Cancer |
| title | Endostatin gene variation and protein levels in breast cancer susceptibility and severity |
| title_full | Endostatin gene variation and protein levels in breast cancer susceptibility and severity |
| title_fullStr | Endostatin gene variation and protein levels in breast cancer susceptibility and severity |
| title_full_unstemmed | Endostatin gene variation and protein levels in breast cancer susceptibility and severity |
| title_short | Endostatin gene variation and protein levels in breast cancer susceptibility and severity |
| title_sort | endostatin gene variation and protein levels in breast cancer susceptibility and severity |
| url | http://www.biomedcentral.com/1471-2407/7/107 |
| work_keys_str_mv | AT coxangela endostatingenevariationandproteinlevelsinbreastcancersusceptibilityandseverity AT globejenny endostatingenevariationandproteinlevelsinbreastcancersusceptibilityandseverity AT crosssimons endostatingenevariationandproteinlevelsinbreastcancersusceptibilityandseverity AT balasubramaniansabapathyp endostatingenevariationandproteinlevelsinbreastcancersusceptibilityandseverity AT brownnicolaj endostatingenevariationandproteinlevelsinbreastcancersusceptibilityandseverity AT reedmalcolmw endostatingenevariationandproteinlevelsinbreastcancersusceptibilityandseverity |